The positive Topline result announcement on 7th March confirmed IMM-124E will proceed into Phase 3, this definitely won't change on next Tuesday's Webinar.
The focus will be if DoD will still interested and willing to provide further funding support of the Phase 3? or Immuron has to find new partners/capital to go ahead along.
Either way they have already mentioned that they'll be seeking none-dilutive funding sources and options.
1 more day to find out...
Ann: Travelan to progress to Phase 3 Clinical Trials in the US, page-196
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
-0.001(1.37%) |
Mkt cap ! $16.72M | |||
| Open | High | Low | Value | Volume |
| 7.2¢ | 7.2¢ | 7.2¢ | $3.325K | 46.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 114000 | 7.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 103395 | 1 |
View Market Depth
| Last trade - 10.56am 12/11/2024 (20 minute delay) ? |
| IMC (ASX) Chart |